Investors comparing defensive equity ETFs often arrive at the same shortlist: IYK and XLP. Both are passive, index-based funds marketed as consumer staples exposure, and both offer lower-volatility, income-oriented positioning during uncertain market cycles. Yet beneath the surface, these two products are not true substitutes. XLP confines itself almost entirely to the consumer staples sector of the S&P 500, while IYK blends staples with a notable allocation to healthcare and basic materials. Understanding that distinction is essential for any investor weighing sector exposure, fund performance, and relative positioning in the current environment. I also checked this using Tickeron’s AI Screener to see how the two line up on key metrics.
Issued by BlackRock, IYK is a passively managed fund that seeks to track the Russell 1000 Consumer Staples 22.5/45 Capped Index, a capped benchmark covering large- and mid-cap U.S. consumer staples companies. The fund generally holds about 54 stocks and is considered non-diversified. Its largest positions are concentrated in branded goods manufacturers: Procter & Gamble, Coca-Cola, and Philip Morris International each represent a double-digit weighting, followed by PepsiCo, CVS Health, Altria Group, McKesson, and Mondelez International.
What distinguishes IYK is its allocation mix: roughly 82–85% of assets sit in consumer staples, about 11% in healthcare, and a small slice in basic materials. This breadth is the primary reason its profile diverges from purer staples funds. The fund charges a net expense ratio of 0.38%, noticeably higher than its large-cap peers, and its five-year beta has historically run below the broader market.
Managed by State Street Global Advisors, XLP seeks to replicate the Consumer Staples Select Sector Index, which represents the consumer staples sector of the S&P 500 as classified under GICS. Launched in 1998, the fund employs a full replication strategy and holds approximately 38 securities, making it more concentrated than IYK. Its top weights skew toward large retailers and distributors: Walmart and Costco Wholesale lead the portfolio, followed by Procter & Gamble, Coca-Cola, Philip Morris International, Altria Group, Mondelez International, PepsiCo, Colgate-Palmolive, and Target.
Approximately 98% of XLP's assets are allocated to consumer staples, with only a marginal consumer cyclical sleeve. Its expense ratio of just 0.08% is among the lowest in the category, and with AUM well above $14 billion, the fund offers deep liquidity and tight trading spreads.
Consumer staples continue to serve as a defensive anchor for portfolios during periods of elevated equity volatility and shifting rate expectations. Household essentials — food, beverages, household products, and tobacco — exhibit relatively stable demand across economic cycles, which supports steady cash flows and dividends. At the same time, the sector faces structural pressures, including persistent input-cost inflation, shifting consumer preferences toward private-label goods, and the rise of GLP-1 weight-loss drugs, which some analysts view as a long-term headwind for packaged-food volumes.
These funds also sit at the intersection of two distinct themes. XLP's heavy weighting in Walmart and Costco ties it closely to consumer discretionary-adjacent retail dynamics and grocery price competition. By contrast, IYK's healthcare sleeve, anchored by CVS Health and McKesson, introduces exposure to pharmacy-benefit and drug-distribution economics — a different set of regulatory and reimbursement risks.
Over recent months and market cycles, the two funds have moved in a similar general direction, as both are dominated by large-cap, defensive franchises with substantial dividend support. However, their relative positioning has diverged meaningfully at the margins. XLP's retail-heavy construction has historically made it more sensitive to shifts in consumer spending trends, grocery pricing, and membership-driven wholesale demand. IYK, with its brand-manufacturer tilt and healthcare allocation, has displayed a modestly lower beta and a smoother drawdown profile over five-year horizons.
From a cost-of-ownership standpoint, XLP holds a clear structural edge. On a $10,000 investment, its 0.08% fee equates to roughly $8 annually versus approximately $38 for IYK — a gap that compounds over long holding periods. Investors prioritizing pure sector exposure and lower volatility may find IYK's broader diversification appealing, while cost-conscious, scale-focused investors are more likely to gravitate toward XLP.
When comparing ETFs like these, I often rely on Tickeron’s AI Screener to quickly surface differences in holdings, costs, and risk metrics that might not be obvious at first glance. It lets me apply consistent filters across sectors and see how structural choices play out in practice, which sharpens the decision process without adding unnecessary complexity.
Based on observable structural factors, Tickeron's AI would currently favor XLP. Its combination of a materially lower expense ratio, far deeper liquidity, and clean, sector-pure consumer staples exposure gives it a durable efficiency advantage. While IYK offers broader diversification and a historically lower beta, its higher cost and cross-sector drift dilute its identity as a pure staples vehicle. In a defensive allocation where cost, scale, and trend consistency matter most, the AI screen leans toward XLP as the more compelling of the two.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IYK as a result. In 70 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for IYK just turned positive on October 07, 2026. Looking at past instances where IYK's MACD turned positive, the stock continued to rise in 37 of 44 cases over the following month. The odds of a continued upward trend are 84%.
IYK moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 265 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 232 of 299 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The 10-day RSI Indicator for IYK moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 32 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 62 cases where IYK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
IYK broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerStaples